As of November 2024, Orchid Pharma has a market cap of $819.41M. This makes Orchid Pharma the world's 8758th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $676.39M | 56.65% |
2023 | $431.80M | 95.71% |
2022 | $220.62M | -7.81% |
2021 | $239.32M | 220.41% |
2020 | $74.69M | 2161.47% |
2019 | $3.30M | 13.54% |
2018 | $2.91M | -74.33% |
2017 | $11.33M | -30.87% |
2016 | $16.39M | -58.54% |
2015 | $39.54M | 0.38% |
2014 | $39.39M | -1.37% |
2013 | $39.94M | -34.59% |
2012 | $61.06M | -20.45% |
2011 | $76.75M | -58.32% |
2010 | $184.14M | 65.36% |
2009 | $111.36M | 100.49% |
2008 | $55.54M | -67.96% |
2007 | $173.35M | 46.02% |
2006 | $118.72M | -18.87% |
2005 | $146.33M | 22.44% |
2004 | $119.51M | 14.25% |
2003 | $104.60M | 232.75% |
2002 | $31.43M | - |